M67.29
Synovial hypertrophy, not elsewhere classified, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Synovial hypertrophy refers to the abnormal thickening of the synovial membrane, which lines the joints and produces synovial fluid essential for smooth movement. When this condition occurs in multiple sites and is not classified under a specific category, it is referred to as 'Synovial hypertrophy, not elsewhere classified, multiple sites' (ICD-10 code M67.29). This condition can cause joint swelling, pain, and stiffness, affecting mobility and quality of life. Recognizing the signs and understanding the potential causes can help in managing symptoms effectively.
Causes & Symptoms
Clinical Causes: Chronic inflammatory conditions such as rheumatoid arthritis or psoriatic arthritis Repeated joint injuries or trauma Joint overuse or repetitive stress activities Degenerative joint diseases like osteoarthritis Infections affecting the joints Certain autoimmune disorders Genetic predispositions and inherited connective tissue disorders
Key Symptoms: Swelling around the affected joints Persistent or joint pain, especially with movement Stiffness, particularly after periods of inactivity Reduced range of motion Warmth or tenderness in affected areas Feeling of increased joint mass or firmness Possible sensations of joint instability or clicking
Diagnostic & Treatment
Diagnosis Path: Joint imaging studies such as X-rays, ultrasound, or MRI to assess joint structure and synovial tissue. Laboratory tests including blood tests to detect markers of inflammation or autoimmune activity. Synovial fluid analysis to identify infection, inflammation, or crystals associated with other joint conditions. Biopsy of synovial tissue in certain cases for detailed examination.
Treatment Protocols: Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain. Disease-modifying antirheumatic drugs (DMARDs) or biologics if autoimmune causes are identified. Physical therapy to strengthen muscles around joints and improve flexibility. Corticosteroid injections directly into affected joints for rapid relief. Rest and activity modification to prevent further joint stress. Surgical intervention in severe cases, which may include synovectomy (removal of hypertrophied synovial tissue) or joint repair or replacement.
Clinical Advice & FAQs
Billing Guidance
Is M67.29 a billable ICD-10 code?
Yes, M67.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M67.29?
Clinical documentation must specify the nature of Synovial hypertrophy, not elsewhere classified, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference